Convalescent plasma may be a possible treatment for COVID-19: A systematic review
- 5 December 2020
- journal article
- review article
- Published by Elsevier BV in International Immunopharmacology
- Vol. 91, 107262
- https://doi.org/10.1016/j.intimp.2020.107262
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Presence of medication taken by blood donors in plasma for transfusionVox Sanguinis, 2014
- The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysisThe Journal of Infectious Diseases, 2014
- Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus InfectionClinical Infectious Diseases, 2011
- Effect of Immunoglobulin Therapy on the Rate of Infections in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation and or treated with immunomodulatory agentsMediterranean Journal of Hematology and Infectious Diseases, 2010
- Treatment with Convalescent Plasma for Influenza A (H5N1) InfectionThe New England Journal of Medicine, 2007
- Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemiaNature Medicine, 2006
- Does blood donor history accurately reflect the use of prescription medications? A comparison of donor history and serum toxicologic analysisTransfusion, 2006
- Use of convalescent plasma therapy in SARS patients in Hong KongEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patientsClinical Microbiology & Infection, 2004